In addition to the layoffs, the company is also looking to divest its Infectious Disease Business. Source: BioSpace

Biogen released its third-quarter financials yesterday, showing total revenues of $3.1B for the quarter, a 4 percent gain compared to the same period the previous year. Source: BioSpace

Corbus' stock popped on the release of topline results from a midstage study involving its lead (and only) clinical drug, anabasum. Source: BioSpace

Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace

If J&J's going to keep rewarding investors, it's going to need these top drugs to continue racking up sales. Source: BioSpace

In order to meet growing demand for insulin, pharma giant Eli Lilly said it will invest $72M to expand insulin manufacturing capabilities at one of its Indianapolis facilities. Source: BioSpace

TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace

ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace

Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze. Source: BioSpace

The company is shuttering its GBT440 program to treat idiopathic pulmonary fibrosis (IPF). Source: BioSpace